FDA gives early OK to Alnylam rare disease drug
November 20, 2019 at 13:02 PM EST
The FDA has approved Alnylam's new product Givlaari, which silences the gene behind a rare metabolic disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|